Pintex Pharmaceuticals Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Pintex Pharmaceuticals General Information

Description

Developer of novel cancer therapeutics and diagnostics. The company's research and development activity is based on the technology that originated at the Salk Institute for Biological Studies and at Harvard University.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 313 Pleasant Street
  • Watertown, MA 02472
  • United States
+1 (617)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 313 Pleasant Street
  • Watertown, MA 02472
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pintex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Apr-2005 Completed Product Development
3. Early Stage VC (Series B) 07-May-2003 Completed Product Development
2. Early Stage VC 18-Apr-2002 $1.1M $4.1M Completed Startup
1. Early Stage VC (Series A) 01-Jan-2000 $3M $3M Completed Startup
To view Pintex Pharmaceuticals’s complete valuation and funding history, request access »

Pintex Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Pintex Pharmaceuticals’s complete cap table history, request access »

Pintex Pharmaceuticals Patents

Pintex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2005094263-A2 Methods of determining the prognosis and treatment of subjects with colon cancer Inactive 23-Mar-2004
WO-2005094263-A3 Methods of determining the prognosis and treatment of subjects with colon cancer Inactive 23-Mar-2004
WO-2005076958-A2 Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders Inactive 05-Feb-2004
WO-2005076958-A3 Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders Inactive 05-Feb-2004
US-20050239095-A1 Use of pin1 inhibitors for treatment of cancer Inactive 19-Sep-2003 G01N33/57575
To view Pintex Pharmaceuticals’s complete patent history, request access »

Pintex Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioVentures Investors Venture Capital Minority
Canaan Partners Venture Capital Minority
Collaborative Seed & Growth Partners Venture Capital Minority
Pod Investment Venture Capital Minority
Zero Stage Capital Venture Capital Minority
To view Pintex Pharmaceuticals’s complete investors history, request access »

Pintex Pharmaceuticals FAQs

  • When was Pintex Pharmaceuticals founded?

    Pintex Pharmaceuticals was founded in 1999.

  • Where is Pintex Pharmaceuticals headquartered?

    Pintex Pharmaceuticals is headquartered in Watertown, MA.

  • What industry is Pintex Pharmaceuticals in?

    Pintex Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Pintex Pharmaceuticals a private or public company?

    Pintex Pharmaceuticals is a Private company.

  • What is Pintex Pharmaceuticals’s current revenue?

    The current revenue for Pintex Pharmaceuticals is .

  • How much funding has Pintex Pharmaceuticals raised over time?

    Pintex Pharmaceuticals has raised $11.7M.

  • Who are Pintex Pharmaceuticals’s investors?

    BioVentures Investors, Canaan Partners, Collaborative Seed & Growth Partners, Pod Investment, and Zero Stage Capital have invested in Pintex Pharmaceuticals.

  • When was Pintex Pharmaceuticals acquired?

    Pintex Pharmaceuticals was acquired on 01-Apr-2005.

  • Who acquired Pintex Pharmaceuticals?

    Pintex Pharmaceuticals was acquired by Vernalis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process